Nurse Practitioner, Adult Health · New York, NY
NPI
1093431975
Since 2022
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
173 Fort Washington Avenue, 4th Floor
New York, NY, 10032
Phone (212) 305-4600
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,399
63 services
Medicare patients, 2024
35
Average age 76
Drug cost, 2024
$2.1M
2,909 prescriptions
Company payments, 2025
$783
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Briella R Villena was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 25 times for 24 patients. In total Briella R Villena billed 63 services in 7 codes, and Medicare paid $4,399.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 25 | 24 | $12.15 | $304 |
| 99215 Office E&M - Established | Office | 19 | 18 | $136.31 | $2,590 |
| 99214 Office E&M - Established | Office | 13 | 12 | $96.80 | $1,258 |
Medicare prescription drug claims, 2024
In 2024, the drug Briella R Villena prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 356 prescriptions and refills. In total Briella R Villena wrote 2,909 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 356 | 774 | 125 | $500K |
| Metoprolol Succinate Generic | 260 | 681 | 91 | $4,724 |
| Jardiance Empagliflozin | 230 | 473 | 78 | $265K |
| Carvedilol Generic | 189 | 444 | 70 | $1,421 |
| Spironolactone Generic | 188 | 488 | 73 | $1,394 |
| Atorvastatin Calcium Generic | 185 | 525 | 75 | $2,210 |
| Eplerenone Generic | 168 | 449 | 61 | $15K |
| Eliquis Apixaban | 155 | 309 | 46 | $180K |
| Farxiga Dapagliflozin Propanediol | 140 | 301 | 47 | $164K |
| Furosemide Generic | 108 | 278 | 58 | $511 |
| Torsemide Generic | 89 | 205 | 40 | $1,432 |
| Rosuvastatin Calcium Generic | 69 | 169 | 29 | $1,180 |
| Ozempic Semaglutide | 63 | 78 | 17 | $70K |
| Losartan Potassium Generic | 49 | 136 | 26 | $249 |
| Xarelto Rivaroxaban | 48 | 93 | 12 | $49K |
Brand drugs: - claims; generic drugs: 1,711 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Briella R Villena $783 ($783 in general payments such as food, travel and fees) from 10 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $183.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $183 |
| Alnylam Pharmaceuticals Inc. ALNY | 5 | $149 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $142 |
| Merck Sharp & Dohme LLC MRK | 4 | $91.22 |
| BridgeBio Pharma, Inc. BBIO | 3 | $82.09 |
| CVRx, Inc. CVRX | 1 | $33.07 |
| Kestra Medical Technology Services, Inc. | 1 | $30.01 |
| Scpharmaceuticals Inc. SCPH | 1 | $26.82 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $24.93 |
| Veloxis Pharmaceuticals, Inc. | 1 | $20.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.